Lucien Blondel on Resolve Stroke: To Be Used In the SCULPT Trial
Lucien Blondel, Co-Founder of Quantum Surgical, shared on LinkedIn:
”Resolve Stroke, a French startup developing an ultrasound-based solution to accelerate time to treatment, announced enrollment of first patient in the SCULPT trial.
Over a 6 month period, data will be collected for up to 50 patients of the neuro-intensive care unit at Montpellier University Hospital.
In ICU, patients admitted after brain injuries require daily monitoring.
Traditional X-ray based imaging is the gold standard but has limitations: transporting vulnerable patients, radiation exposure, logistics, etc.
The company led by Aritz Zamacola is betting on advanced software that would transform raw acoustic data into biomarkers.
The SYLVER system enables live imaging of cerebral vasculature and perfusion directly at patient’s bedside.”
Stay updated with Hemostasis Today.
-
Apr 15, 2026, 21:27Satish Bondala: Blood Bank and Transfusion Services – The Lifeline of Hospitals
-
Apr 15, 2026, 21:26Tareq Abadl: Understanding Thalassemia – Breaking the ‘Ordinary Anemia’ Myth
-
Apr 15, 2026, 21:24Wolfgang Miesbach: Key Message from John Semple on Platelets as Immune Cells in ITP
-
Apr 15, 2026, 21:22Manuel Gutiérrez de Ravé: Promotion to Real-World Evidence Scientist at Terumo Blood and Cell Technologies
-
Apr 15, 2026, 18:45Elias Lee: Acute PE from Subclavian VT – CT Scan Diagnosis, Radiology Interpretation, and Emergency Imaging Insights
-
Apr 15, 2026, 17:30Rivaroxaban versus Aspirin after Atrial Fibrillation Ablation – Cardiology Insights and Heart Health
-
Apr 15, 2026, 17:01Emmanuel J Favaloro: A Practical Approach to Inherited and Acquired Coagulation Disorders
-
Apr 15, 2026, 16:55Chokri Ben Lamine: VA-ECMO vs VV-ECMO Thromboembolic Events – Key Clinical Pearls
-
Apr 15, 2026, 16:54Augustina Isioma Ikusemoro: The Most Misunderstood Cause of a Prolonged APTT in the Laboratory